MENU
VTRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Viatris (VTRS) Earnings Date & Reports

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs... Show more

A.I. Advisor
published Earnings

VTRS is expected to report earnings to fall 17.48% to 55 cents per share on March 02

Viatris VTRS Stock Earnings Reports
Q4'25
Est.
$0.55
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.04
The last earnings report on November 06 showed earnings per share of 67 cents, beating the estimate of 62 cents. With 2.76M shares outstanding, the current market capitalization sits at 12.68B.
View a ticker or compare two or three
VTRS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VTRS showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
1000 Mylan Boulevard
Phone
+1 724 514-1800
Employees
38000
Web
https://www.viatris.com